Similarly, Ahmad et al. (2020) reported that lupeol reduced Alzheimer’s disease pathology in an Aβ1–42-induced mouse model by reducing β-amyloid accumulation and downregulating beta-secretase-1 (BACE-1) expression. This evidence concerns the gene BACE1 and early-onset autosomal dominant Alzheimer disease.